CSafe, LLC
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
CSafe, LLC - overview
Established
1979
Location
Monroeville, OH, US
Primary Industry
Logistics & Distribution
About
CSafe, LLC is a US-based company specializing in temperature-controlled cold chain solutions tailored for the life sciences sector, ensuring safe transport of critical medical products. CSafe, LLC, founded in 1979 and headquartered in Monroeville, US, provides innovative shipping solutions for the life sciences. Currently led by CEOs Alan Saffer and Patrick Schafer, the company has closed 2 major deals, the latest being on January 6, 2021. CSafe specializes in providing temperature-controlled cold chain solutions designed for the life sciences sector.
Their core offerings encompass active and passive shipping systems for applications including cell and gene therapy, clinical trials, and commercial distribution, ensuring sensitive medical products are transported under precise temperature controls. The company's portfolio includes advanced solutions like CGT Ultra D, launched to enhance cold chain performance, and they serve a global clientele including pharmaceutical companies and clinical research organizations across North America, Europe, and Asia-Pacific. CSafe primarily generates revenue through B2B transactions by supplying temperature-controlled shipping solutions to pharmaceutical and biotechnology companies. Their revenue model includes both per-shipment purchases and long-term contracts, with flagship products such as those in the CGT line contributing significantly to sales.
Pricing plans are customized based on shipment volumes and client specifications, reflecting their commitment to addressing diverse commercialization needs. CSafe aims to enhance its product offerings with new solutions designed for the evolving needs of the life sciences industry. The funding obtained from the recent deal on January 6, 2021, will be leveraged to support these product developments and facilitate expansion into additional markets, particularly targeting regions in Europe and Asia-Pacific by 2023. The company continues to explore innovative shipping solutions to address the growing demands of pharmaceutical and biotechnology sectors.
Current Investors
Frazier Healthcare Partners, Thomas H. Lee Partners, Altaris
Primary Industry
Logistics & Distribution
Sub Industries
Packaging
Website
www.csafeglobal.com/
Verticals
Manufacturing
Total Amount Raised
Subscriber access only
CSafe, LLC - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on, Trade Sale | Completed | Softbox Systems Ltd. | - | ||||||||
| Secondary Buyout | Completed | CSafe, LLC | - | ||||||||
| Recapitalisation | Completed | CSafe, LLC | - |
Displaying 1 - 3 of 3
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.